Hidden blood loss in anterior cervical discectomy and fusion versus single-level anterior cervical corpectomy and fusion with adjacent discectomy for two-level cervical spondylotic myelopathy

双节段颈椎病脊髓病患者行前路颈椎间盘切除融合术与单节段前路颈椎椎体切除融合术联合邻近椎间盘切除术的隐性出血比较

阅读:1

Abstract

OBJECTIVES: This study aims to evaluate hidden blood loss (HBL) in patients undergoing anterior cervical surgery for two-level cervical spondylotic myelopathy (CSM) and to compare the HBL between anterior cervical discectomy and fusion (ACDF) and single-level anterior cervical corpectomy and fusion (ACCF) with adjacent discectomy. PATIENTS AND METHODS: Between January 2019 and December 2023, a total of 100 patients (55 males, 45 females; mean age: 49.4±11.4 years; range, 43 to 84 years) who underwent anterior cervical surgeries were retrospectively analyzed. Data collection encompassed demographic information, laboratory findings, and clinical records. Patients treated with ACDF were classified as Group A, while those receiving ACCF were assigned to Group B. Total blood loss (TBL) was calculated using the Gross formula, and HBL was determined based on TBL, postoperative drainage volume, and intraoperative blood loss. RESULTS: The most frequently affected segments were C3/4 and C4/5. The mean operative time was 135.5±13.4 min in Group A versus 139.5±12.8 min in Group B, indicating no statistically significant difference (p=0.130). The mean intraoperative blood loss and HBL were 42.5±9.2 mL and 231.5±55.0 mL in Group A, respectively, compared to 53.4±9.02 mL and 262.8±53.3 mL in Group B. Both parameters showed statistically significant intergroup differences (intraoperative blood loss: TBL: p<0.001; HBL: p=0.005). Hemoglobin (Hb) loss was significantly lower in Group A than in Group B, demonstrating a statistically significant difference (p<0.001). CONCLUSION: In the perioperative period of anterior cervical surgery for two-level CSM (primarily C3/4-C4/5), HBL represents a clinically significant factor which should not be overlooked. Compared to ACDF, greater attention should be paid to postoperative anemia and HBL in patients undergoing ACCF.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。